Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
Another Clinical Trial Setback For Rigel Pharma's Lead Program, This Time For COVID-19
November 02, 2022
Tickers
RIGL
From Benzinga
Pfizer's Q3 Earnings Surpasses Estimates, Lifts Forecasts For COVID-19 Vaccine Sales By $2B
November 01, 2022
Tickers
PFE
From Benzinga
From Benzinga
National Institutes of Health's Long COVID Initiative To Assess Pfizer's Antiviral Pill As Potential Treatment
October 28, 2022
Tickers
PFE
From Benzinga
From Benzinga
From Benzinga
European Regulatory Authority Backs Approval For Moderna's New Omicron Targeted COVID-19 Booster
October 19, 2022
Tickers
MRNA
From Benzinga
RedHill Biopharma Shares Surge New Treatment Patent For Its Late-Stage COVID-19 Candidate
October 19, 2022
Tickers
RDHL
From Benzinga
This Addiction Drug Shows Some Potential Against Long COVID Symptoms
October 19, 2022
From Benzinga
Moderna Inks Deal For Updated COVID Shots For Low Income Countries
October 17, 2022
Tickers
MRNA
From Benzinga
Once Favored By Late Shinzo Abe, Japan Culls Development On Repurposed COVID-19 Treatment
October 14, 2022
From Benzinga
Pfizer/BioNTech's Updated Omicron Adapted COVID-19 Shot Increases Neutralizing Antibodies Above Pre-Booster Levels
October 13, 2022
From Benzinga
Yet Another Good News For Moderna, FDA Approves Its New Omicron Adapted COVID-19 Shot
October 12, 2022
From Benzinga
US Health Official Says Updated COVID-19 Boosters Should Offer Protection Amid Tracking Emerging Variants
October 12, 2022
From Benzinga
Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests
October 12, 2022
From Benzinga
From Benzinga
Pfizer's Executive Says European COVID-19 Vaccine Contract Negotiations Did Not Happen Over Text Message
October 10, 2022
From Benzinga
From Benzinga
Rebound In COVID-19 Symptoms After Pfizer's Antiviral Pill Might Be Due To Stronger Immune Response
October 07, 2022
Tickers
PFE
From Benzinga
Oramed Pharmaceuticals' Oral COVID-19 Vaccine Candidate Shows Safety, Immunogenicity In Early Study
October 07, 2022
Tickers
ORMP
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
